Inflation Reduction Act Imposes Prescription Drug Pricing Reforms
Healthcare Law Insights blog
NOVEMBER 8, 2022
The Act includes provisions targeting Medicare prescription drug costs, which could have wide-ranging effects for any party involved in the pharmaceutical industry, including drug developers, researchers, manufacturers, distributors, insurance companies, pharmacy associations and consumers.
Let's personalize your content